Aimei Health Technology Co
AFJK
26 hedge funds and large institutions have $66.2M invested in Aimei Health Technology Co in 2024 Q1 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
82.21% more ownership
Funds ownership: 0% → 82.21% (+82%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$11.2M |
| 2 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$6.92M |
| 3 |
GCL
Glazer Capital LLC
New York
|
+$5.59M |
| 4 |
WC
Wealthspring Capital
West Harrison,
New York
|
+$5.46M |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$4.64M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $10 | +$10 | +1 | New |
|
AFJK Hedge Fund Activity: Q1 2024 in Review
26 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in Aimei Health Technology Co (AFJK) for Q1 2024, worth a combined $66.2M.
Buyers outnumbered sellers: 26 funds opened new AFJK positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Karpus Investment Management, opening a new position worth an estimated $11.2M.
- 26 institutional investors held Aimei Health Technology Co (AFJK) as of Q1 2024, up from 0 in Q4 2023.
- Funds reported $66.2M of Aimei Health Technology Co stock for Q1 2024.
- 26 funds opened new Aimei Health Technology Co positions in Q1 2024 and 0 closed out, a net change of +26 holders.
- The largest Aimei Health Technology Co buyer in Q1 2024 was Karpus Investment Management, an estimated $11.2M added.
Based on aggregated 13F filings for Q1 2024.